Risk factors
Cardio Diagnostics Holdings (CDIO) risk factors
Item 1A of every Cardio Diagnostics Holdings, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors64 risks2 new5 dropped6 reworded
Revenue dropped to $14,825 in 2025 with net losses of $6,498,167 and an accumulated deficit of $29,250,000.
Filed Mar 13, 2026 - FY2024 10-K risk factors67 risks
Cardio Diagnostics is a pre-revenue medical diagnostics company relying heavily on external financing and key university-licensed intellectual property. The company faces severe operational, competitive, and regulatory risks in the unproven epigenetic and cardiovascular testing markets.
Filed Mar 20, 2025